| Pharmaceutical active ingredients: |
| CarbidopaLevodopa |
| Available forms, composition and doses of Sinemet LP: |
| Tablets, Prolonged Release; Oral; Carbidopa 100 mg; Levodopa 25 mgTablets, Prolonged Release; Oral; Carbidopa 200 mg; Levodopa 50 mg |
| Sinemet LP medical category: |
| Human:Antiparkinsonian drugsDopamine precursorsMiscellaneous central nervous system agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BA02 - Levodopa and decarboxylase inhibitor |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbMerck |
| Related documents and information about Sinemet LP: |
| Sinemet prescribing information (PDF)Sinemet CR prescribing information (PDF) |